More recently, we showed in the imiquimod-induced psoriasis model in mice, known to be IL-22 dependent, that in vivo neutralisation of IL-22BP with the same neutralising antibody used in the present study led to increased severity of psoriasis-like skin inflammation41. The gene discussed is IL22; the disease is psoriasis.